Literature DB >> 31393574

Blood-Brain Barrier Dysfunction in Idiopathic Intracranial Hypertension.

Md Mahdi Hasan-Olive1,2, Hans-Arne Hansson3, Rune Enger4,5, Erlend A Nagelhus4,5, Per Kristian Eide1,2.   

Abstract

Idiopathic intracranial hypertension (IIH) is traditionally considered benign and characterized by symptoms related to increased intracranial pressure, including headache and impaired vision. We have previously demonstrated that brains of IIH patients exhibit patchy astrogliosis, increased perivascular expression of the water channel aquaporin-4 (AQP4) as well as degenerating pericyte processes and capillary basement membranes. Given the established association between pericyte degeneration and blood-brain barrier (BBB) dysfunction, we investigated blood protein leakage by light microscopic immunohistochemistry. We also assessed perivascular AQP4 expression by immunogold transmission electron microscopy. The study included 14 IIH patients and 14 reference (REF) subjects undergoing neurosurgery for epilepsy, aneurysm, or tumor. Evidence of BBB dysfunction, measured as area extravasated fibrinogen/fibrin, was significantly more pronounced in IIH than REF individuals. The extent of extravasated fibrinogen was positively correlated with increasing degree of astrogliosis and vascular AQP4 immunoreactivity, determined by light microscopy. Immunogold transmission electron microscopy revealed no overall changes in AQP4 expression at astrocytic vascular endfeet in IIH (n = 8) compared to REF (n = 11) individuals. Our results provide evidence of BBB leakage in IIH, signifying that IIH is a more serious neurodegenerative disease than previously considered.
© 2019 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  AQP4; Benign intracranial hypertension; Fibrinogen/fibrin extravasation; Immunogold electron microscopy; Neurodegeneration; Neurovascular unit; Pseudotumor cerebri

Mesh:

Substances:

Year:  2019        PMID: 31393574     DOI: 10.1093/jnen/nlz063

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  12 in total

1.  Population pharmacokinetic modeling of CSF to blood clearance: prospective tracer study of 161 patients under work-up for CSF disorders.

Authors:  Markus Herberg Hovd; Espen Mariussen; Hilde Uggerud; Aslan Lashkarivand; Hege Christensen; Geir Ringstad; Per Kristian Eide
Journal:  Fluids Barriers CNS       Date:  2022-07-01

2.  Impaired glymphatic function in idiopathic intracranial hypertension.

Authors:  Per Kristian Eide; Are Hugo Pripp; Geir Ringstad; Lars Magnus Valnes
Journal:  Brain Commun       Date:  2021-03-21

3.  Hypoxemia increases blood-brain barrier permeability during extreme apnea in humans.

Authors:  Damian M Bailey; Anthony R Bain; Ryan L Hoiland; Otto F Barak; Ivan Drvis; Christophe Hirtz; Sylvain Lehmann; Nicola Marchi; Damir Janigro; David B MacLeod; Philip N Ainslie; Zeljko Dujic
Journal:  J Cereb Blood Flow Metab       Date:  2022-01-21       Impact factor: 6.960

Review 4.  Preclinical update on regulation of intracranial pressure in relation to idiopathic intracranial hypertension.

Authors:  Sajedeh Eftekhari; Connar Stanley James Westgate; Maria Schmidt Uldall; Rigmor Hoejland Jensen
Journal:  Fluids Barriers CNS       Date:  2019-11-26

Review 5.  Blood-brain barrier disruption in atrial fibrillation: a potential contributor to the increased risk of dementia and worsening of stroke outcomes?

Authors:  Ritambhara Aryal; Adjanie Patabendige
Journal:  Open Biol       Date:  2021-04-21       Impact factor: 6.411

6.  Blood-brain barrier disruption and ventricular enlargement are the earliest neuropathological changes in rats with repeated sub-concussive impacts over 2 weeks.

Authors:  Bailey Hiles-Murison; Andrew P Lavender; Mark J Hackett; Joshua J Armstrong; Michael Nesbit; Samuel Rawlings; Terrence McGonigle; Andrew Warnock; Virginie Lam; John C L Mamo; Melinda Fitzgerald; Ryu Takechi
Journal:  Sci Rep       Date:  2021-04-29       Impact factor: 4.379

Review 7.  Cerebrospinal fluid dynamics in idiopathic intracranial hypertension: a literature review and validation of contemporary findings.

Authors:  Aku L Kaipainen; Erik Martoma; Tero Puustinen; Joona Tervonen; Henna-Kaisa Jyrkkänen; Jussi J Paterno; Anna Kotkansalo; Susanna Rantala; Ulla Vanhanen; Ville Leinonen; Soili M Lehto; Matti Iso-Mustajärvi; Antti-Pekka Elomaa; Sara Qvarlander; Terhi J Huuskonen
Journal:  Acta Neurochir (Wien)       Date:  2021-08-27       Impact factor: 2.216

Review 8.  An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Klaus J Wirth; Carmen Scheibenbogen; Friedemann Paul
Journal:  J Transl Med       Date:  2021-11-22       Impact factor: 5.531

9.  Clinical application of intrathecal gadobutrol for assessment of cerebrospinal fluid tracer clearance to blood.

Authors:  Per K Eide; Espen Mariussen; Hilde Uggerud; Are H Pripp; Aslan Lashkarivand; Bjørnar Hassel; Hege Christensen; Markus Herberg Hovd; Geir Ringstad
Journal:  JCI Insight       Date:  2021-05-10

10.  Increased occurrence of pathological mitochondria in astrocytic perivascular endfoot processes and neurons of idiopathic intracranial hypertension.

Authors:  Per Kristian Eide; Md Mahdi Hasan-Olive; Hans-Arne Hansson; Rune Enger
Journal:  J Neurosci Res       Date:  2020-10-26       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.